Skip to main content
drug protocol number
CS-CTP-AD5NCOV-ⅢCo
drug sponsor
MOH / CanSino
drug study
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
drug trial site
King Fahad Medical City (Riyadh)
drug status
Rejected
drug phase